To improve the field’s understanding of MBNL1-directed transcriptome maturation, Kalen Robeson will use human iPSC models to determine the role of MBNL1 in differentiation into skeletal muscle and to determine the function of MBNL1 in the muscle tissue resident stem cell response to injury. The goal is to produce insights that will advance regenerative treatments to restore lost muscle function.